Frontiers in Surgery (Aug 2022)

A waterproof, low-cost dressing system reduces postoperative wound dressing changes in primary total hip arthroplasty: An efficacy study

  • Shilong Su,
  • Shilong Su,
  • Chenggong Wang,
  • Fawei Gao,
  • Yihe Hu,
  • Yihe Hu,
  • Yihe Hu,
  • Da Zhong,
  • Da Zhong,
  • Pengfei Lei,
  • Pengfei Lei,
  • Pengfei Lei

DOI
https://doi.org/10.3389/fsurg.2022.966874
Journal volume & issue
Vol. 9

Abstract

Read online

BackgroundsPostoperative wound complication is a major risk factor for the development of Periprosthetic joint infection. We innovatively invented a new dressing system to reduce the occurrence of postoperative wound complications and improve the quality of life of patients after total hip arthroplasty.MethodsA total of 120 patients who underwent primary unilateral total hip arthroplasty were enrolled in this study. The data collected included the number of dressing changes, costs of the dressings, postoperative hospital stay, The Visual Analogue Scale (VAS) score, The Harris Hip Score (HHS), ASEPSIS score, The Stony Brook Scar Evaluation Scale (SBSES), wound complications, the frequency of showers and satisfaction. Data were statistically analyzed.ResultsThe average number of dressing changes was 0.74 ± 0.46, while the average postoperative hospital stay was 3.67 ± 0.97 days. The average cost of the new dressings throughout a treatment cycle was 57.42 ± 15.18 dollars. The VAS score decreased from 5.63 ± 1.09 before the operation to 0.88 ± 0.54 one month after the operation. The HHS score increased from 70.18 ± 7.84 before the operation to 80.36 ± 4.08 one month after the operation. The results of the four indexes of the ASEPSIS score were all 0. The SBSES score was 3.55 ± 0.61 at two weeks after the operation, and 4.38 ± 0.71 at one month after the operation. No wound complications were recorded until one month after the operation when the satisfaction rate was 92.53 ± 3.62%.ConclusionIn this study, we have invented a new dressing system for surgical wounds after total hip arthroplasty and confirmed its efficacy.Chinese Clinical Trial RegistryChiCTR2000033822, Registered 13/ June/2020

Keywords